Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1990 Nov;212(5):621–628. doi: 10.1097/00000658-199011000-00010

Surgical management of pheochromocytoma with the use of metyrosine.

R R Perry 1, H R Keiser 1, J A Norton 1, R T Wall 1, C N Robertson 1, W Travis 1, H I Pass 1, M M Walther 1, W M Linehan 1
PMCID: PMC1358191  PMID: 1978640

Abstract

Despite recommended preoperative preparation with alpha-adrenergic blockers, severe hemodynamic instability may occur during operations to resect pheochromocytoma. We combined the alpha-blocker phenoxybenzamine with the tyrosine hydroxylase inhibitor metyrosine in an attempt to better manage the hypertension of patients with pheochromocytoma undergoing surgical resection. This report reviews the cases of 25 consecutive patients undergoing surgery for known intra-abdominal pheochromocytoma. Each patient had elevated serum or urine levels of catecholamines or their metabolites. Nineteen patients were prepared before operation with phenoxybenzamine and metyrosine and six patients were given phenoxybenzamine alone. There were no significant differences in maximum, minimum, or mean blood pressure before or after tumor resection between patients who received metyrosine and those who did not. However careful review suggested that those who received metyrosine had more severe disease as judged by biochemical criteria. Study of selected patients matched for age and severity of disease suggested that the intraoperative blood pressure management of patients prepared with phenoxybenzamine and metyrosine was facilitated. In addition metyrosine-prepared patients lost less blood and required less volume replacement during surgery than did non-metyrosine-prepared patients. There were no apparent differences in postoperative fluid requirements. Although the study is not a prospective randomized trial, a retrospective review of patients managed with the combination of phenoxybenzamine and metyrosine suggests that surgery to resect pheochromocytoma can be better performed with both drugs than with phenoxybenzamine alone. The combination regimen appears to result in better blood pressure control, less blood loss, and the need for less intraoperative fluid replacement than does the traditional method of single-agent alpha-adrenergic blockade.

Full text

PDF
621

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beard C. M., Sheps S. G., Kurland L. T., Carney J. A., Lie J. T. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1983 Dec;58(12):802–804. [PubMed] [Google Scholar]
  2. Bergman S. M., Sears H. F., Javadpour N., Keiser H. R. Postoperative management of patients with pheochromocytoma. J Urol. 1978 Jul;120(1):109–112. doi: 10.1016/s0022-5347(17)57063-9. [DOI] [PubMed] [Google Scholar]
  3. Bornemann M., Hill S. C., Kidd G. S., 2nd Lactic acidosis in pheochromocytoma. Ann Intern Med. 1986 Dec;105(6):880–882. doi: 10.7326/0003-4819-105-6-880. [DOI] [PubMed] [Google Scholar]
  4. Bravo E. L., Gifford R. W., Jr Current concepts. Pheochromocytoma: diagnosis, localization and management. N Engl J Med. 1984 Nov 15;311(20):1298–1303. doi: 10.1056/NEJM198411153112007. [DOI] [PubMed] [Google Scholar]
  5. Cousins M. J., Rubin R. B. The intraoperative management of phaeochromocytoma with total epidural sympathetic blockade. Br J Anaesth. 1974 Jan;46(1):78–81. doi: 10.1093/bja/46.1.78. [DOI] [PubMed] [Google Scholar]
  6. Cullen M. L., Staren E. D., Straus A. K., Doolas A., Shah R., Patel S., Economou S. G. Pheochromocytoma: operative strategy. Surgery. 1985 Nov;98(5):927–930. [PubMed] [Google Scholar]
  7. Desmonts J. M., Marty J. Anaesthetic management of patients with phaeochromocytoma. Br J Anaesth. 1984 Jul;56(7):781–789. doi: 10.1093/bja/56.7.781. [DOI] [PubMed] [Google Scholar]
  8. Engelman K., Horwitz D., Jéquier E., Sjoerdsma A. Biochemical and pharmacologic effects of alpha-methyltyrosine in man. J Clin Invest. 1968 Mar;47(3):577–594. doi: 10.1172/JCI105754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GIFFORD R. W., Jr, KVALE W. F., MAHER F. T., ROTH G. M., PRIESTLEY J. T. CLINICAL FEATURES, DIAGNOSIS AND TREATMENT OF PHEOCHROMOCYTOMA: A REVIEW OF 76 CASES. Mayo Clin Proc. 1964 Apr;39:281–302. [PubMed] [Google Scholar]
  10. Green K. N., Larsson S. K., Beevers D. G., Bevan P. G., Hayes B. Alpha-methyltyrosine in the management of phaeochromocytoma. Thorax. 1982 Aug;37(8):632–633. doi: 10.1136/thx.37.8.632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hauptman J. B., Modlinger R. S., Ertel N. H. Pheochromocytoma resistant to alpha-adrenergic blockade. Arch Intern Med. 1983 Dec;143(12):2321–2323. [PubMed] [Google Scholar]
  12. Hauss J., Moeller A., Bünte H. Adrenalectomy in adrenal hypertension. Cardiology. 1985;72 (Suppl 1):167–173. doi: 10.1159/000173968. [DOI] [PubMed] [Google Scholar]
  13. Havlik R. J., Cahow C. E., Kinder B. K. Advances in the diagnosis and treatment of pheochromocytoma. Arch Surg. 1988 May;123(5):626–630. doi: 10.1001/archsurg.1988.01400290112020. [DOI] [PubMed] [Google Scholar]
  14. Hull C. J. Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management. Br J Anaesth. 1986 Dec;58(12):1453–1468. doi: 10.1093/bja/58.12.1453. [DOI] [PubMed] [Google Scholar]
  15. Levine S. N., McDonald J. C. The evaluation and management of pheochromocytomas. Adv Surg. 1984;17:281–313. [PubMed] [Google Scholar]
  16. Maton P. N., Norton J. A., Nieman L. K., Doppman J. L., Jensen R. T. Multiple endocrine neoplasia type II with Zollinger-Ellison syndrome caused by a solitary pancreatic gastrinoma. JAMA. 1989 Jul 28;262(4):535–537. [PubMed] [Google Scholar]
  17. Newell K. A., Prinz R. A., Brooks M. H., Glisson S. N., Barbato A. L., Freeark R. J. Plasma catecholamine changes during excision of pheochromocytoma. Surgery. 1988 Dec;104(6):1064–1073. [PubMed] [Google Scholar]
  18. Pullerits J., Ein S., Balfe J. W. Anaesthesia for phaeochromocytoma. Can J Anaesth. 1988 Sep;35(5):526–534. doi: 10.1007/BF03026905. [DOI] [PubMed] [Google Scholar]
  19. Ram C. V., Meese R., Hill S. C. Failure of alpha-methyltyrosine to prevent hypertensive crisis in pheochromocytoma. Arch Intern Med. 1985 Nov;145(11):2114–2115. [PubMed] [Google Scholar]
  20. Samaan N. A., Hickey R. C., Shutts P. E. Diagnosis, localization, and management of pheochromocytoma. Pitfalls and follow-up in 41 patients. Cancer. 1988 Dec 1;62(11):2451–2460. doi: 10.1002/1097-0142(19881201)62:11<2451::aid-cncr2820621134>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  21. Stenström G., Haljamäe H., Tisell L. E. Influence of pre-operative treatment with phenoxybenzamine on the incidence of adverse cardiovascular reactions during anaesthesia and surgery for phaeochromocytoma. Acta Anaesthesiol Scand. 1985 Nov;29(8):797–803. doi: 10.1111/j.1399-6576.1985.tb02303.x. [DOI] [PubMed] [Google Scholar]
  22. Stenström G., Kutti J. The blood volume in pheochromocytoma patients before and during treatment with phenoxybenzamine. Acta Med Scand. 1985;218(4):381–387. doi: 10.1111/j.0954-6820.1985.tb08862.x. [DOI] [PubMed] [Google Scholar]
  23. Sutton M. G., Sheps S. G., Lie J. T. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc. 1981 Jun;56(6):354–360. [PubMed] [Google Scholar]
  24. van Heerden J. A., Sheps S. G., Hamberger B., Sheedy P. F., 2nd, Poston J. G., ReMine W. H. Pheochromocytoma: current status and changing trends. Surgery. 1982 Apr;91(4):367–373. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES